(Bloomberg) -- Wealth manager Azura hired an heir to a Swiss watchmaking fortune who previously worked for Monaco’s government to help build up its operations in Europe.
Crain's restaurants and retail reporter Ally Marotti talks with host Amy Guth about the return of one of Chicago's most famed restaurants.
Breaking: Stefano Pessina to near-double stake in Walgreens after Sycamore Partners takeover–reports
Another ‘go big or go home’ move by Signor Pessina. The Financial Times reports this afternoon from “people familiar with the matter” that Walgreens Boots Alliance chairman Stefano Pessina will nearly ...
The Trump administration granted Nippon Steel and United States Steel Corporation (NYSE:X) a 21-day extension in their lawsuit over the proposed merger, allowing further negotiations with regulators.
The executive chairman of Walgreens Boots Alliance (NASDAQ:WBA), Stefano Pessina, is expected to nearly double his company ownership to about 30% after the U.S. pharmacy chain completes its buyout ...
Stefano Pessina, executive chairman of Walgreens Boots Alliance, is set to nearly double his stake in the pharmacy retail chain as part of the $10 billion take-private deal the company announced ...
15d
MoneyWeek on MSNWalgreens Boots Alliance sold to private equity firm - will Boots get the boot?US pharmacy giant Walgreens Boots Alliance is going private. Will the new owners sell off the high-street chemist?
Gazprom Neft is ready to raise oil output from April under the OPEC+ agreement, the head of the Russian oil producer said on Tuesday.
Stefano Pessina will increase his stake in Walgreens from 17% to approximately 30% as part of Sycamore's $23.7 billion takeover. Walgreens' market value has dropped from over $100 billion post ...
Walgreens Boots Alliance's executive chair Stefano Pessina will almost double his stake in the US pharmacy group to about 30% as part of its $10 billion (€9.14 billion) takeover by private ...
(Reuters) - Walgreens Boots Alliance's executive chair Stefano Pessina will almost double his stake in the US pharmacy group to about 30% as part of its takeover by private equity group Sycamore, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results